SCHEMBL26698299

SCHEMBL26698299

CC(C(=O)O)c1ccn(C)c(=O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 12/20 0.64
PTGS1 P23219 9/20 0.46
AKR1C3 P42330 6/20 0.44
AKR1C2 P52895 6/20 0.44
MAPT P10636 3/20 0.44
SLC22A6 Q4U2R8 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 2/20 0.44
HPGD P15428 2/20 0.44
HIF1A Q16665 2/20 0.44
TSHR P16473 2/20 0.44
CYP1A2 P05177 2/20 0.44
FABP2 P12104 1/20 0.44
AKR1C4 P17516 1/20 0.44
ADRA2B P18089 1/20 0.44
CHRM3 P20309 1/20 0.44
HTR2C P28335 1/20 0.44
DRD3 P35462 1/20 0.44
AKR1C1 Q04828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18515684 0.82 PTGS2 (0.44) PTGS2LMNATSHRKDM4EMAPK1
SCHEMBL21138968 0.77 PTGS2 (0.38) PTGS2CYP2C9CYP2C19KDM4E
SCHEMBL6487655 0.76 AKR1C3 (0.51) PTGS2PTGS1AKR1C3AKR1C2SLC22A6
SCHEMBL17981958 0.76 PTGS2 (0.37) PTGS2CYP2C9CYP2C19KDM4E
SCHEMBL22214088 0.76 PTGS2 (0.37) PTGS2CYP2C9CYP2C19KDM4E
SCHEMBL19002518 0.76 TUBB4A (0.38) PTGS2CYP2C9CYP2C19KDM4E
SCHEMBL3670299 0.75 AKR1C3 (0.50) PTGS2PTGS1AKR1C3AKR1C2SLC22A6
SCHEMBL25884992 0.73 HDAC4 (0.45) PTGS2LMNAHPGDTSHRCYP2C9
SCHEMBL21983488 0.70 HDAC6 (0.33) PTGS2CYP2C9CYP2C19CYP3A4
SCHEMBL20832598 0.70 PRMT5 (0.36) PTGS2CYP2C9CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023226965-A1 ROCK INHIBITORS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2023-11-30 WO disclosed